Literature DB >> 28071656

ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

Francis A Farraye1, Gil Y Melmed2, Gary R Lichtenstein3, Sunanda V Kane4.   

Abstract

Recent data suggest that inflammatory bowel disease (IBD) patients do not receive preventive services at the same rate as general medical patients. Patients with IBD often consider their gastroenterologist to be the primary provider of care. To improve the care delivered to IBD patients, health maintenance issues need to be co-managed by both the gastroenterologist and primary care team. Gastroenterologists need to explicitly inform the primary care provider of the unique needs of the IBD patient, especially those on immunomodulators and biologics or being considered for such therapy. In particular, documentation of up to date vaccinations are crucial as IBD patients are often treated with long-term immune-suppressive therapies and may be at increased risk for infections, many of which are preventable with vaccinations. Health maintenance issues addressed in this guideline include identification, safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, melanoma and non-melanoma skin cancer as well as identification of depression and anxiety and smoking cessation. To accomplish these health maintenance goals, coordination between the primary care provider, gastroenterology team and other specialists is necessary.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28071656     DOI: 10.1038/ajg.2016.537

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  174 in total

1.  Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in Belgium.

Authors:  J F Rahier; T Moreels; P De Munter; G D'Haens
Journal:  Acta Gastroenterol Belg       Date:  2010 Jan-Mar       Impact factor: 1.316

2.  Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Scott A Harper; Keiji Fukuda; Nancy J Cox; Carolyn B Bridges
Journal:  MMWR Recomm Rep       Date:  2003-09-26

3.  A 'cocoon immunization strategy' among patients with inflammatory bowel disease.

Authors:  Karolina Waszczuk; Ewa Waszczuk; Agata Mulak; Leszek Szenborn; Leszek Paradowski
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-03       Impact factor: 2.566

4.  Fracture risk is increased in Crohn's disease, but not in ulcerative colitis.

Authors:  P Vestergaard; K Krogh; L Rejnmark; S Laurberg; L Mosekilde
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

Review 5.  Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis.

Authors:  Jonathan Ariyaratnam; Venkataraman Subramanian
Journal:  Am J Gastroenterol       Date:  2014-01-14       Impact factor: 10.864

Review 6.  Improving quality of care in inflammatory bowel disease: what changes can be made today?

Authors:  Julián Panés; Marian O'Connor; Laurent Peyrin-Biroulet; Peter Irving; Joel Petersson; Jean-Frédéric Colombel
Journal:  J Crohns Colitis       Date:  2014-04-06       Impact factor: 9.071

7.  Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors.

Authors:  J R Goodhand; M Wahed; J E Mawdsley; A D Farmer; Q Aziz; D S Rampton
Journal:  Inflamm Bowel Dis       Date:  2012-02-22       Impact factor: 5.325

8.  Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.

Authors:  Ali M Abbas; Rawaa M Almukhtar; Edward V Loftus; Gary R Lichtenstein; Nabeel Khan
Journal:  Am J Gastroenterol       Date:  2014-09-23       Impact factor: 10.864

Review 9.  Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.

Authors:  Alicia C Marín; Javier P Gisbert; María Chaparro
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

10.  Insufficient knowledge of korean gastroenterologists regarding the vaccination of patients with inflammatory bowel disease.

Authors:  Yoon Suk Jung; Jung Ho Park; Hong Joo Kim; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim; Dong Il Park
Journal:  Gut Liver       Date:  2014-05       Impact factor: 4.519

View more
  119 in total

1.  Vaccination of Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.

Authors:  Sheena Crosby; Michael J Schuh; Freddy Caldera; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-01

Review 2.  Is tofacitinib a game-changing drug for ulcerative colitis?

Authors:  Fernando Magro; Maria Manuela Estevinho
Journal:  United European Gastroenterol J       Date:  2020-06-18       Impact factor: 4.623

3.  Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005-2016).

Authors:  Christopher Ma; Matthew K Smith; Leonardo Guizzetti; Remo Panaccione; Gilaad G Kaplan; Kerri L Novak; Cathy Lu; Reena Khanna; Brian G Feagan; Siddharth Singh; Vipul Jairath; Ashwin N Ananthakrishnan
Journal:  Clin Gastroenterol Hepatol       Date:  2020-01-25       Impact factor: 11.382

4.  More Skin in the Game: Screening for Skin Cancer in IBD Patients.

Authors:  Seema A Patil; Raymond K Cross
Journal:  Dig Dis Sci       Date:  2018-10       Impact factor: 3.199

Review 5.  A Practical Guide to the Safety and Monitoring of New IBD Therapies.

Authors:  Benjamin Click; Miguel Regueiro
Journal:  Inflamm Bowel Dis       Date:  2019-04-11       Impact factor: 5.325

Review 6.  A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD.

Authors:  Kenechukwu O Chudy-Onwugaje; Kaci E Christian; Francis A Farraye; Raymond K Cross
Journal:  Inflamm Bowel Dis       Date:  2019-04-11       Impact factor: 5.325

7.  Improving IBD Care: A Personalized Approach to Management.

Authors:  Stephen B Hanauer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-03

8.  Lax Prophylaxis: Vaccinating the Inflammatory Bowel Disease Patient.

Authors:  Grigoriy E Gurvits
Journal:  Dig Dis Sci       Date:  2018-01       Impact factor: 3.199

Review 9.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

10.  Bi-layered Tubular Microfiber Scaffolds as Functional Templates for Engineering Human Intestinal Smooth Muscle Tissue.

Authors:  Ying Chen; Chengchen Guo; Eleana Manousiouthakis; Xiuli Wang; Dana M Cairns; Terrence T Roh; Chuang Du; David L Kaplan
Journal:  Adv Funct Mater       Date:  2020-02-27       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.